🧬 Latest Breakthroughs in Endocrinology: Gene Therapy, Semaglutide, AI & More 🧬
In this week’s Endocrinology Update, we cover the latest innovations transforming diabetes care, bone health, cardiovascular risk management, and reproductive medicine. From cutting-edge gene therapies and dual-action inflammation targeting for Type 1 diabetes, to Novo Nordisk’s promising oral GLP-1 therapy—this video brings you the future of endocrinology, today.
📌 In This Episode:
✔️ Genprex and University of Pittsburgh partner to advance diabetes gene therapy
✔️Dual-action inflammation targeting shows new promise for Type 1 diabetes
✔️ Study exposes racial disparities in access to advanced diabetes technologies
✔️ Stem cell-derived vesicles offer new pathways for pancreatic cell repair
✔️ Novo Nordisk reports positive Phase III results for oral GLP-1 therapy
✔️ Osteoboost launches FDA-cleared wearable to combat bone loss
✔️ AI model predicts cardiovascular risk in Chinese patients with Type 2 diabetes
✔️ Metabolomics identifies new biomarkers for poor ovarian response in IVF
Whether you’re a healthcare professional, researcher, or patient advocate, this update is packed with insights you won’t want to miss.
📢 Stay Ahead in Endocrinology Research!
✅ Like, share, and subscribe for weekly updates on endocrinology and metabolic diseases.
🔔 Turn on notifications so you never miss an update!
#Endocrinology #DiabetesResearch #GeneTherapy #BoneHealth #AIinHealthcare #IVFSuccess #MedicalInnovation #HealthcareUpdates #ClinicalResearch